Local view for "http://purl.org/linkedpolitics/eu/plenary/2007-03-14-Speech-3-294"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2007-03-14"^^xsd:date2
dcterms:Is Part Of	lp_eu:Council Question Time2
dcterms:Language	"de"^^xsd:language2
lpv:document identification number	"en.20070314.20.3-294"2
lpv:hasSubsequent	lp_eu:2007-03-14-Speech-3-2952
lpv:speaker	lp:Gernot Erler2
lpv:translated text	". The honourable Member is right: the licensing of this vaccine to protect against human papillomavirus does indeed represent important progress in the prevention of cervical cancer. After all, it is claimed that the vaccine affords protection from this cancer in 96–100% of cases. This vaccine is still very new, however, and – as the honourable Member also mentioned – any vaccination and information strategies are still in the early stages of development. Therefore, the emphasis is still on the exchange of know-how and experience at the moment. Nevertheless, we also believe that protection can be significantly improved by means of information campaigns and the implementation of the existing screening guidelines on the subject."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph